UDK: 615.212.7:616-092.9
O. Y. Grechko, N. V. Eliseeva, D. M. Chikun, A. A. Spasov, V. A. Anisimova
Волгоградский государственный медицинский университет, кафедра фармакологии
We studied the efficacy of RU-1203 compound exhibiting kappa-agonist activity with different routes of administration. It is established that the compound RU-1203 shows the greatest analgesic efficacy when administered intravenously; it is also active when administered orally, in contrast to butorphanol, the reference drug.
kappa-opioid receptor, agonist, opioid analgesics